FDA Inspection
Wells Pharmacy, IncWells Pharmacy, Inc – FDA Inspection, Jan 28, 2021
Record Details
This FDA Inspection record concerns Wells Pharmacy, Inc, with an inspection on January 28, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Wells Pharmacy, Inc
- Inspection Date
- January 28, 2021
- Product Type
- Drugs
View Company Profile
ID · 9b4df99a-70a7-4af6-904f-ca963054bd6f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1135134
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Enforcement
- Untitled Letter
FDA Citations
6- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.25(b)Supervisor Training/Education/Experience
- 21 CFR 211.22(c)Approve or reject procedures or specs
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Wells Pharmacy, Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 9, 2026 | Not classified | New Orleans District Office | Drug Quality Assurance |
| April 25, 2025 | VAI | New Orleans District Office | Drug Quality Assurance |
| April 27, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 20, 2016 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Wells Pharmacy, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.